Priority Date: 14.06.16 (US 201662350017P)

SENSITIZATION OF TUMORS TO THERAPIES THROUGH ENDOGLIN ANTAGONISM

  • Application ID: EP17814046
  • Status: Request for examination was made

Applicant

Research organisation logo small
Research Organisation

Attorney

no operation time available
Headquarter in London and 6 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 227 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 14.06.2016 - Priority Date (US 201662350017P)
  • 21.12.2017 - Publication A1 (WO2017218708)
  • 17.04.2019 - Publication A1 (EP3468601)